BTG PLC Notice of Results (6000M)
14 October 2016 - 10:46PM
UK Regulatory
TIDMBTG
RNS Number : 6000M
BTG PLC
14 October 2016
BTG plc: Notice of Results
London, UK, 14 October 2016: BTG plc (LSE: BTG), the specialist
healthcare company, announces that it will be releasing its
unaudited interim results for the six months ended 30 September
2016 (the "Interim Results") on Thursday 15 November 2016.
For further information contact:
BTG FTI Consulting
Andy Burrows, VP Corporate Mo Noonan / Hanna Skeppner
& Investor Relations
+44 (0)20 7575 1741; Mobile:
+44 (0)7990 530 605 +44 (0)20 3727 1000
Stuart Hunt, Investor Relations
Manager
+44 (0)20 7575 1582; Mobile:
+44 (0)7815 778 536
Chris Sampson, Corporate
Communications Director
+44 (0)20 7575 1595; Mobile:
+44 (0)7773 251 178
About BTG
BTG is a growing international specialist healthcare company
bringing to market innovative products in specialist areas of
medicine to better serve doctors and their patients. We have a
portfolio of Interventional Medicine products to advance the
treatment of cancer, severe emphysema, severe blood clots and
varicose veins, and Specialty Pharmaceuticals that help patients
overexposed to certain medications or toxins. Inspired by patient
and physician needs, BTG is investing to expand its portfolio to
address some of today's most complex healthcare challenges. To
learn more about BTG, please visit: www.btgplc.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORLLFSLIRLSLIR
(END) Dow Jones Newswires
October 14, 2016 07:46 ET (11:46 GMT)
Btg (LSE:BTG)
Historical Stock Chart
From Apr 2024 to May 2024
Btg (LSE:BTG)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Btg Plc (London Stock Exchange): 0 recent articles
More BTG News Articles